who invented glp 1 Svetlana Mojsov has been edged out of the Ozempic origins story History of glucagon-like peptide-1 receptor

Luo L, Ramanathan R, Horlbogen L, Mathialagan S, Costales C, Vourvahis M, et al

When dosing insulin in an acute care setting, its always safer to leave the patient in a mildly hyperglycemic range

The Inflation Reduction Acts drug pricing provisions have begun to address this indirectly, but the rebate trap remains a significant barrier to biosimilar uptake as of 2026

(7) Within activated macrophages, GHK-Cu apparently lowered intracellular reactive oxygen species and nudged superoxide dismutase activity back toward baseline

This possibly occurs by stimulation of the RANKL pathway and inhibition of production of the decoy receptor for RANKL/osteoprotegerin, which differs from findings from preclinical studies [92]